Publication

2025:

  1. Turner EL, Preisser JS, Zhang Y, Wang X, Toles M, Cykert S, Li F, Rathouz PJ (2025). Analysis of stepped-wedge cluster randomized trials: A tutorial using marginal models. Statistics in Medicine.
  2. Wang H*, Chen X, Courtright K, Halpern S, Harhay MO, Taljaard M, Li F (2025). On anticipation effect in stepped wedge cluster randomized trials. Statistics in Medicine. [Pre-print]
    • (*Winner of the 2025 Biostatistics master’s thesis prize at the Yale School of Public Health*)
  3. Kahan BC, Bahti M, Bi D, Bretz F, Collins GS, Copas A, Harhay MO, Li F, Auriemma CL (2025). Development of a consensus extension of the estimands framework for cluster randomised trials (CRT-estimands): results from a Delphi study. Trials.
  4. Murad MH, Ramachandran N, Lin L, Li F (2025). Regression to the mean: A primer for evidence-based medicine practitioners. BMJ Evidence-Based Medicine.
  5. Fang X, Uno H, Li F (2025). While-alive regression analysis of composite survival endpoints. Biostatistics.
  6. Cheng C, Liu B, Wruck L, Li F, Li F (2025). Multiply robust estimation for causal survival analysis with treatment noncompliance. The Annals of Applied Statistics. [Pre-print]
  7. Tong J, Li F, Tong G (2025). Addressing cluster-level treatment effect heterogeneity in sample size determination for hierarchical 2 × 2 factorial designs. Biometrical Journal.
  8. Salerno S, Roberts EK, Needham BL, McCormick TH, Li F, Mukherjee B, Shi X. (2025) What’s the weight? Estimating controlled outcome differences in complex surveys for health disparities research. Statistics in Medicine.
  9. Bi D, Copas A, Li F, Kahan BC (2025). A scoping review identified additional considerations for defining estimands in cluster randomised trials. Journal of Clinical Epidemiology.
  10. Tong J, Cheng C, Tong G, Harhay MO, Li F (2025). Doubly robust estimation and sensitivity analysis with outcomes truncated by death in multi-arm clinical trials. Statistics in Medicine.
  11. Chen T, Li F, Wang R (2025). Network generalized estimating equations for complexly correlated data with applications to cluster randomized trials. Biostatistics.
  12. Tong J, Kahan BC, Harhay MO, Li F (2025). Semiparametric principal stratification beyond monotonicity. Statistica Sinica.
  13. Davis-Plourde K, Goldfeld K, Allore H, Taljaard M, Li F. (2025) Designing stepped wedge cluster randomized trials with a baseline measurement of the outcome. Statistics in Medicine.
  14. Li F, Tong J, Cheng C, Fang X, Kahan BC, Wang B (2025). Model-robust standardization in cluster-randomized trials. Statistics in Medicine.
  15. Ohnishi Y*, Li F (2025). A Bayesian nonparametric approach to mediation and spillover effects with multiple mediators in cluster-randomized trials. Journal of the American Statistical Association (Theory and Methods).
    • (*Winner of 2025 JSM Early Career Award, ASA Section on Statistics in Epidemiology*)
  16. Liu J, Li F, Sutcliffe S, Colditz GA (2025). Selecting the optimal longitudinal cluster randomized design: parallel-arm, crossover or stepped-wedge. Statistical Methods in Medical Research.
  17. Zampieri FG, Cahusac PMB, Maia IS, Yehya N, Meyer N, Li F, Harhay MO (2025). Trial analysis and interpretation in critical care using the evidential (likelihood) approach: Rationale and practical considerations. American Journal of Respiratory and Critical Care Medicine.
  18. Cao Z, Li F (2025). Assessing mediation in cross-sectional stepped wedge cluster randomized trials. Statistics in Medicine. [Pre-print]
  19. Maleyeff L, Li F, Haneuse S, Wang R (2025). Permutation tests for detecting treatment effect heterogeneity in cluster randomized trials. Statistical Methods in Medical Research.
  20. Lu H, Zivich PN, Rudolph JE, Liew Z, Mukherjee B, Li F (2025). Revisiting representativeness. International Journal of Epidemiology.
  21. Baumann MR, Esserman D, Taljaard M, Li F (2025). Power calculation for cross-sectional stepped wedge cluster randomized trials with a time-to-event endpoint. Biometrics.
  22. Cheng C, Li F (2025). Identification and multiply robust estimation in causal mediation analysis across principal strata. Journal of the Royal Statistical Society: Series B (Statistical Methodology).
  23. Agarwal AK, Ebert JP, Xiong R, Ali Z, Lee D, Shofer F, Gitleman Y, Do D, Spencer E, Grenader EM, Li F, Harhay MO, Delgado MK (2025). Peer and patient feedback to increase adherence to post-operative opioid prescribing guidelines: A stepped wedge cluster randomized trial. JAMA Surgery.
  24. Liu R, Hu L, Wilson FP, Warren JL, Li F (2025). A Bayesian approach to the g-formula via iterative conditional regression. Statistics in Medicine.
  25. Chen X, Hu L, Li F (2025). A flexible Bayesian g-formula for causal survival analyses with time-dependent confounding. Lifetime Data Analysis.
  26. Cantu E, Isenberg D, Marquis A, Alcudia A, Yusuf S, Saleh A, Raevsky A, Li F, Harhay MO (2025). A pilot study to capture provider perspectives on clinically relevant effects in thoracic transplant trials. American Journal of Respiratory and Critical Care Medicine.
  27. Hemming K, Thompson JY, Hooper RL, Ukoumunne OC, Li F, Caille A, Kahan BC, Leyrat C, Grayling MJ, Mohammed NI, Thompson JA, Giraudeau B, Turner EL, Watson S, Goulao B, Kasza J, Forbes AB, Copas A, Taljaard M (2025). Guidelines for the content of statistical analysis plans for cluster randomized trials: protocol paper. Trials. 26(1), 72.
  28. Munroe ES, Spicer A, Dianti J, Castellvi-Font A, Linck EG, Talisa V, Urner M, Zalucky A, Angus DC, Baedorf-Kassis E, Blette B, Bos L, Buell K, Casey JD, Calfee C, Del Sorbo L, Ferguson ND, Giblon R, Harhay MO, Heath A, Houle T, Jiang C, Kramer L, Lawler PR, Leligdowicz A, Li F, Liu K, Maiga A, Maslove D, McArthur C, Mcauley D, Oosthuysen C, Prescott HC, Rochwerg B, Sahetya S, Samoilenko M, Schnitzer M, Seitz KP, Shah F, Sinha P, Slutsky A, Qian E, Zampieri F, Zarychanski R, Churpek M, Fan E, Semler M, Goligher EC, for the Platform of Randomized Adaptive Clinical Trials in Critical Illness (PRACTICAL) investigators and the Evidence-based Individualized Treatment Effects (EvITE) Group (2025). Evidence-based precision medicine in critical care: A framework for quantifying and applying individualized treatment effects in critically ill patients. The Lancet Respiratory Medicine.
  29. Lee KM, Li F (2025). How should parallel cluster randomized trials with a baseline period be analyzed? A survey of estimands and common estimators. Biometrical Journal.
  30. Cheng C*, Spiegelman DS, Li F (2025). Correcting for bias due to mismeasured exposure in mediation analysis with a survival outcome. Journal of the Royal Statistical Society: Series C (Applied Statistics).
    • (*Winner of 2025 PhD Research Prize at Yale School of Public Health*)
  31. Berge LI, Angeles RC, Gedde MH, Fæø SE, Mannseth J, Gedde M, Vislapuu M, Puaschitz NGS, Hillestad E, Aarsland D, Achterberg WP, Allore H, Ballard C, Li F, Selbæk GG, Vahia IV, Husebo BS (2025). Burden and care time for dementia caregivers in the LIVE@Home.Path trial. Alzheimer’s & Dementia.
  32. Gasparini A, Hoogendijk EO, Crowther MJ, Li F, Harhay MO (2025). Analysis of cohort stepped wedge cluster-randomized trials with non-ignorable dropout via joint modeling. Statistics in Medicine.

2024:

  1. Li F, Wang B, Heagerty PJ (2024). What is a stepped wedge cluster randomized trial? JAMA Internal Medicine.
  2. Papadogeorgou G, Liu B, Li F, Li F (2024). Addressing selection bias in cluster randomized experiments via weighting. Biometrics.
  3. Isenberg D, Harhay MO, Mitra N, Li F (2024). Weighting methods for estimating survivor average causal effects in cluster-randomized trials. Statistical Methods in Medical Research.
  4. Tong G, Coronado G, Li C, Li F (2024). Randomized in error in pragmatic clinical trials. Contemporary Clinical Trials.
  5. Lu H, Li F, Lesko CR, Fink DS, Rudolph KE, Harhay MO, Rentsch CT, Fiellin DA, Gonsalves GS (2024). Four Targets: An enhanced framework for guiding causal inference with observational data. International Journal of Epidemiology.
  6. Angriman F, Momenzade N, Adhikari NK, Mouncey PR, Asfar P, Yarnell CJ, Ong S, Pinto R, Doidge JC, Shankar-Hari M, Harhay MO, Masse M, Harrison DA, Rowan KM, Li F, Carter F, Camirand-Lemyre F, Lamontagne F (2024). Blood pressure targets for critically ill adults with vasodilatory shock—An individual patient data meta-analysis. NEJM Evidence.
  7. Bahti M, Brennan K, Li F, Harhay MO, Auriemma CL (2024). Prioritizing attributes of approaches to analyzing patient-centered outcomes that are truncated due to death in critical care clinical trials: A Delphi study. Trials.
  8. Zhu C, Dreyer RP, Li F, Spatz ES, Caraballo-Cordovez C, Mahajan S, Raparelli V, Leifheit EC, Lu Y, Krumholz HM, Spertus JA, D’Onofrio G, Pilote L, Lichtman JH (2024). Depression and low social support mediate the association of marital stress and 12-month cardiac-specific quality of life in young adults with acute myocardial infarction. Biopsychosocial Science and Medicine.
  9. Aklilu AM, Menez S, Baker ML, Brown D, Brown D, Dircksen KK, Dunkley KA, Correa Gaviria S, Farrokh S, Faulkner SC, Jones C, Kadhim BA, Le D, Li F, Makhijani A, Martin M, Moledina DG, Coronel-Moreno C, O’Connor KD, Shelton K, Shvets K, Srialluri N, Tan JW, Testani JM, Corona-Villalobos CP, Yamamoto Y, Parikh CR, Wilson FP, for the KAT-AKI Team (2024). Early, individualized recommendations for hospitalized patients with acute kidney injury: A randomized clinical trial. JAMA.
  10. Cao Z, Ghazi L, Mastrogiacomo C, Forastiere L, Wilson FP, Li F (2024). Using overlap weights to address extreme propensity scores in estimating restricted mean counterfactual survival times. American Journal of Epidemiology.
  11. Tian X*, Li F, Shen L, Esserman D, Zhao Y (2024). Bayesian pathway analysis over brain network mediators for survival data. Biometrics.
    • (*Winner of 2023 ENAR Distinguished Student Paper Award & 2023 John Van Ryzin Award*)
  12. Cheng C, Li F (2024). Inverting estimating equations for causal inference on quantiles. Biometrika.
  13. Wang B, Wang X, Li F (2024). How to achieve model-robust inference in stepped wedge trials with model-based methods? Biometrics.
  14. Chen X, Li F (2024). Model-assisted analysis of covariance estimators for stepped wedge cluster randomized experiments. Scandinavian Journal of Statistics.
  15. Ouyang Y, Li F, Li X, Bynum J, Mor V, Taljaard M (2024). Estimates of intra-cluster correlation coefficients from 2018 USA Medicare data to inform the design of cluster randomized trials in Alzheimer’s and Related Dementias. Trials.
  16. Tong G, Nevins P, Ryan M, Davis-Plourde D, Ouyang Y, Macedo JP, Meng C, Wang X, Caille A, Li F, Taljaard M (2024). A review of current practice in the design and analysis of extremely small stepped-wedge cluster randomized trials. Clinical Trials.
  17. Moyer JC, Li F, Cook AJ, Heagerty PJ, Pals SL, Turner EL, Wang R, Zhou Y, Yu Q, Wang X, Murray DM (2024). Evaluating analytic models for individually randomized group treatment trials with complex clustering in nested and crossed designs. Statistics in Medicine.
  18. Lelutiu-Weinberger C, Filimon ML, Zavodszky AM, Lixandru M, Hanu L, Fierbinteanu C, Patrascu R, Streinu-Cercel A, Luculescu S, Bora M, Filipescu I, Jianu C, Heightow-Weidman LB, Rochelle A, Yi B, Golub SA, van Dyk IS, Burger J, Li F, Pachankis JE (2024). Prepare Romania: Study protocol for a randomized controlled trial of an intervention to promote pre-exposure prophylaxis adherence and persistence among gay, bisexual, and other men who have sex with men. Trials.
  19. Wang B, Harhay MO, Tong J, Small D, Morris T, Li F (2024). On the mixed-model analysis of covariance in cluster-randomized trials. Statistical Science. [Pre-print]
  20. Cheng C*, Hu L, Li F (2024). Doubly robust estimation and sensitivity analysis for marginal structural quantile models. Biometrics.
    • (*Honorable Mention of 2022 ACIC Thomas Ten Have Award*)
    • (*Winner of 2023 ICHPS Student Travel Award*)
    • (*Winner of 2023 ENAR Distinguished Student Paper Award*)
    • (*Winner of 2023 JSM Early Career Paper Award, ASA Biometrics Section*)
  21. Kahan BC, Blette B, Harhay M, Halpern S, Jairath V, Copas A, Li F (2024). Demystifying estimands in cluster randomised trials. Statistical Methods in Medical Research.
  22. Ouyang Y, Taljaard M, Forbes AB, Li F (2024). Maintaining the validity of inference from linear mixed models in stepped-wedge cluster randomized trials under misspecified random-effects structures. Statistical Methods in Medical Research.
  23. Liu J, Li F (2024). Optimal designs using generalized estimating equations in cluster randomized crossover and stepped wedge trials. Statistical Methods in Medical Research.
  24. Cheng C, Guo Y, Liu B, Wruck L, Li F, Li F (2024). Multiply robust estimation of principal causal effects with noncompliance and survival outcomes. Clinical Trials.
  25. Wang X, Chen X, Goldfeld KS, Taljaard M, Li F (2024). Sample size and power calculation for testing treatment effect heterogeneity in cluster randomized crossover designs. Statistical Methods in Medical Research.
  26. Blette BS, Halpern SD, Li F, Harhay MO (2024). Assessing treatment effect heterogeneity in the presence of missing effect modifier data in cluster-randomized trials. Statistical Methods in Medical Research.
  27. Oikonomou EK, Holste G, Yuan N, Coppi A, McNamara RL, Haynes N, Vora AN, Velazquez EJ, Li F, Menon V, Kapadia SR, Gill TM, Nadkarni GN, Krumholz HM, Wang Z, Ouyang D, Khera R (2024). A multimodality video-based AI biomarker for aortic stenosis development and progression. JAMA Cardiology.
  28. Barsotti G, Luciano R, Kumar A, Meliambro K, Kakade V, Tokita J, Naik A, Fu J, Peck E, Pell J, Reghuvaran A, Tanvir EM, Patel P, Zhang W, Li F, Moeckel G, Perincheri S, Cantley L, Moledina D, Wilson FP, He JC, Menon MC (2024). Rationale and design of phase 2, double-blind, placebo-controlled, randomized trial evaluating AMPK-activation by metformin in focal segmental glomerulosclerosis. Kidney International Reports.
  29. Fay M, Li F (2024). Causal interpretation of the hazard ratio in randomized clinical trials. Clinical Trials.
  30. Rabideau DJ, Li F, Wang R (2024). Multiply robust generalized estimating equations in cluster randomized trials with missing outcomes. Statistics in Medicine.
  31. Tian X*, Ciarleglio M, Cai J, Greene EJ, Esserman DA, Li F, Zhao Y (2024). Bayesian semi-parametric inference for clustered recurrent events with zero-inflation and a terminal event. Journal of the Royal Statistical Society: Series C (Applied Statistics).
    • (*Winner of 2023 JSM Student Paper Award, ASA Section on Bayesian Statistical Science*)
  32. Tinetti ME, Hashmi A, Ng H, Doyle M, Goto T, Esterson J, Naik A, Dindo L, Li F (2024). Identifying and aligning care with the health priorities of older adults with multiple conditions: A nonrandomized clinical trial. JAMA Network Open.
  33. Cao Z, Cho Y, Li F (2024). Transporting randomized trial results to estimate counterfactual survival functions in target populations. Pharmaceutical Statistics.
  34. Zhu C, Dreyer RP, Li F, Spatz ES, Caraballo-Cordovez C, Mahajan S, Raparelli V, Leifheit EC, Lu Y, Krumholz HM, Spertus JA, D’Onofrio G, Pilote L, Lichtman JH (2024). Association of marital/partner status with hospital readmission among young adults with Acute Myocardial Infarction. PLoS ONE.
  35. Tian Z, Li F (2024). Information content of stepped wedge designs under the working independence assumption. Journal of Statistical Planning and Inference.

2023:

  1. Li F, Chen X, Tian Z, Wang R, Heagerty PJ (2023). Planning stepped wedge cluster randomized trials to detect treatment effect heterogeneity. Statistics in Medicine.
  2. Wang B, Chan P, Small D, Li F (2023). Model-robust and efficient covariate adjustment for cluster-randomized experiments. Journal of the American Statistical Association (Theory and Methods).
  3. Wang X, Turner EL, Li F (2023). Designing individually randomized group treatment trials with repeated outcome measurements using generalized estimating equations. Statistics in Medicine.
  4. Liu R, Li F, Esserman D, Ryan MM (2023). Group sequential two-stage preference designs. Statistics in Medicine.
  5. Yao X, Attia ZI, Behnken EM, Hart MS, Inselman SA, Weber KC, Li F, Stricker NH, Stricker JL, Friedman PA, Noseworthy PA (2023). Realtime Diagnosis from Electrocardiogram Artificial Intelligence-Guided Screening for Atrial Fibrillation with Long Follow-Up (REGAL): Rationale and design of a pragmatic, decentralized, randomized controlled trial. American Heart Journal.
  6. Wang W, Hirani SP, Newman SP, Halpern SD, Small, DS, Tong G, Li F, Harhay MO (2023). A mixed model approach to estimate the survivor average causal effect in cluster-randomized trials. Statistics in Medicine.
  7. Wang X, Goldfeld K, Taljaard M, Li F (2023). Sample size requirements to test subgroup-specific treatment effects in cluster-randomized trials. Prevention Science.
    • (*Special Issue on Design and Analytic Methods to Evaluate Multilevel Interventions to Reduce Health Disparities*)
  8. Nevins P, Ryan M, Davis-Plourde K, Ouyang Y, Macedo JP, Meng C, Tong G, Wang X, Ortiz-Reyes L, Caille A, Li F, Taljaard M (2023). Adherence to key recommendations for design and analysis of Stepped-Wedge Cluster Randomized Trials: A Review of trials published 2016-2022. Clinical Trials.
  9. Maleyeff L, Wang R, Haneuse S, Li F (2023). Sample size requirements for testing treatment effect heterogeneity in cluster randomized trials with binary outcomes. Statistics in Medicine.
  10. Thomas LE, Thomas S, Li F, Matsouaka R (2023). Addressing substantial covariate imbalance with propensity score stratification and balancing weights: Connections and recommendations. Epidemiologic Methods.
  11. Chen X, Esserman DA, Li F (2023). Competing risks regression for clustered survival data via the marginal additive subdistribution hazards model. Statistica Neerlandica.
  12. Hu L, Ji J, Joshi H, Scott E, Li F (2023). Estimating the causal effects of multiple intermittent treatments with application to COVID-19. Journal of the Royal Statistical Society: Series C (Applied Statistics).
  13. Tong G, Tong J, Li F (2023). Designing multicenter individually randomized group treatment trials. Biometrical Journal.
  14. Zhu C, Dreyer RP, Li F, Spatz ES, Caraballo-Cordovez C, Mahajan S, Raparelli V, Leifheit EC, Lu Y, Krumholz HM, Spertus JA, D’Onofrio G, Pilote L, Lichtman JH (2023). Impact of marital stress on 12-month health outcomes among young adults with acute myocardial infarction. Journal of the American Heart Association.
  15. Chen X, Harhay MO, Tong G, Li F (2023). A Bayesian machine learning approach for estimating heterogeneous survivor causal effects: Applications to a critical care trial. The Annals of Applied Statistics.
  16. Zhang Y, Preisser JS, Li F, Turner EL, Rathouz PJ (2023). %CRTFASTGEEPWR: A SAS macro for power of generalized estimating equations analysis of multi-period cluster randomized trials with application to stepped wedge designs. Journal of Statistical Software.
  17. Ryan M, Esserman DA, Li F (2023). Maximin optimal cluster randomized designs to detect treatment effect heterogeneity. Statistics in Medicine.
  18. Tong G, Taljaard M, Li F (2023). Sample size considerations for assessing treatment effect heterogeneity in randomized trials with heterogeneous intracluster correlations and variances. Statistics in Medicine.
  19. Kahan BC, Li F, Blette BS, Jairath V, Copas A, Harhay MO (2023). Informative cluster size in cluster-randomised trials: A case study from the TRIGGER trial. Clinical Trials.
  20. Blette BS, Moutchia J, Al-Naamani N, Ventetuolo CE, Cheng C, Appleby D, Urbanowicz R, Fritz J, Mazurek J, Li F, Kawut SM, Harhay MO (2023). Is low risk status a surrogate outcome in pulmonary arterial hypertension? An analysis of three randomized trials. The Lancet Respiratory Medicine.
  21. Ouyang Y, Hemming K, Li F, Taljaard M (2023). Estimating intra-cluster correlation coefficients for planning longitudinal cluster randomized trials: A tutorial. International Journal of Epidemiology.
  22. Meng C, Ryan M , Rathouz PJ, Turner EL, Preisser JS, Li F (2023). ORTH.Ord: An R package for analyzing correlated ordinal outcomes using alternating logistic regression with orthogonalized residuals. Computer Methods and Programs in Biomedicine.
  23. Blette BS, Granholm A, Li F, Shankar-Hari M, Lange T, Munch MW, Møller MH, Perner A, Harhay MO (2023). Causal Bayesian machine learning to assess treatment effect heterogeneity by dexamethasone dose for patients with COVID-19 and severe hypoxemia. Scientific Reports.
  24. Wilson FP, Yamamoto Y, Martin M, Coronel-Moreno C, Li F, Cheng C, Aklilu A, Ghazi L, Greenberg JH, Latham S, Melchinger H, Mansour S, Moledina DG, Parikh CR, Partridge C, Testani J, Ugwuowo U (2023). A randomized clinical trial assessing the effect of automated medication-targeted alerts on acute kidney injury outcomes. Nature Communications.
  25. Nevins P, Davis-Plourde K, Macedo JP, Ouyang Y, Meng C, Ryan M, Tong G, Wang X, Ortiz-Reyes L, Li F, Caille A, Taljaard M (2023). A scoping review described diversity in methods of randomization and reporting of baseline balance in stepped-wedge cluster randomized trials. Journal of Clinical Epidemiology.
  26. Tong J, Li F, Harhay MO, Tong G (2023). Accounting for expected attrition in the planning of cluster randomized trials for assessing treatment effect heterogeneity. BMC Medical Research Methodology.
  27. Ouyang Y, Kulkarni MA, Protopopoff N, Li F, Taljaard M (2023). Accounting for complex intracluster correlations in longitudinal cluster randomized trials: A case study in malaria vector control. BMC Medical Research Methodology.
  28. Cheng C*, Spiegelman D, Li F (2023). Mediation analysis in the presence of continuous exposure measurement error. Statistics in Medicine.
    • (*Winner of 2022 JSM Young Investigator Award, ASA Section on Statistics in Epidemiology*)
  29. Zhu Y, Mitra N, Hemming K, Harhay MO, Li F (2023). Leveraging baseline covariates in analyzing small cluster-randomized trials with a rare binary outcome. Biometrical Journal.
  30. Kahan BC, Cro S, Li F, Harhay MO (2023). Eliminating ambiguous treatment effects using estimands. American Journal of Epidemiology.
  31. Zhang Y, Preisser JS, Li F, Turner EL, Toles M, Rathouz PJ (2023). GEEMAEE: A SAS macro for the analysis of correlated outcomes based on GEE and finite-sample adjustments with application to cluster randomized trials. Computer Methods and Programs in Biomedicine.
  32. Nicholls SG, Al-Jaishi AA, Niznick H, Carroll K, Madani MT, Peak KD, Madani L, Nevins P, Adisso L, Li F, Weijer C, Mitchell S, Welch V, Quinones AR, Taljaard M (2023). Health equity considerations in pragmatic trials in Alzheimer’s and dementia disease: Results from a methodological review. Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring.
  33. Tong G, Li F, Chen X, Hirani SP, Newman SP, Wang W, Harhay MO (2023). A Bayesian approach for estimating the survivor average causal effect when outcomes are truncated by death in cluster-randomized trials. American Journal of Epidemiology.

2022:

  1. Davis-Plourde K, Taljaard M, Li F (2022). Power analyses for stepped wedge designs with multivariate continuous outcomes. Statistics in Medicine.
  2. Wang X, Turner EL, Li F (2022). Improving sandwich variance estimation for marginal Cox analysis of cluster randomized trials. Biometrical Journal.
  3. Maleyeff L, Li F, Haneuse S, Wang R (2022). Assessing exposure-time treatment effect heterogeneity in stepped wedge cluster randomized trials. Biometrics.
  4. Ghazi L, Li F, Simonov M, Yamamoto Y, Nugent JT, Greenberg JH, Bakhoum C, Peixoto A, Wilson, FP (2022). Effect of intravenous antihypertensives on outcomes of severe hypertension in hospitalized patients without acute target organ damage. Journal of Hypertension.
  5. Meng C, Esserman D, Li F, Zhao Y, Blaha O, Lu W, Wang Y, Peduzzi P, Greene EJ (2022). Simulating time-to-event data subject to competing risks and clustering: A review and synthesis. Statistical Methods in Medical Research.
  6. Li F, Li F (2022). Using propensity scores for racial disparity analysis. Observational Studies.
  7. Zhang Y, Preisser JS, Turner EL, Rathouz PJ, Toles M, Li F (2022). A general method for calculating power for GEE analysis of complete and incomplete stepped wedge cluster randomized trials. Statistical Methods in Medical Research.
  8. Li F, Kasza J, Turner EL, Rathouz PJ, Forbes AB, Preisser JS (2022). Generalizing the information content for stepped wedge designs: A marginal modeling approach. Scandinavian Journal of Statistics.
  9. Li F, Tian Z, Tian Z, Li F (2022). A note on identification of causal effects in cluster randomized trials with post-randomization selection bias. Communications in Statistics – Theory and Methods.
  10. Blaha O, Esserman D, Li F (2022). Design and analysis of cluster randomized trials with survival outcomes under the additive hazards mixed model. Statistics in Medicine.
  11. Li F, Chen X, Tian Z, Esserman DA, Heagerty PJ, Wang R (2022). Designing three-level cluster randomized trials to assess treatment effect heterogeneity. Biostatistics.
  12. Kahan B, Li F, Copas AJ, Harhay MO (2022). Estimands in cluster-randomised trials: choosing analyses which answer the right question. International Journal of Epidemiology.
  13. Gallis J, Wang X, Rathouz PJ, Preisser JS, Li F, Turner EL (2022). power swgee: GEE-based power calculation in stepped wedge cluster randomized trials. The Stata Journal.
  14. Ouyang Y, Li F, Preisser JS, Taljaard M (2022). Sample size calculators for planning stepped-wedge cluster randomized trials: A review and comparison. International Journal of Epidemiology.
  15. Yang S*, Moerbeek M, Taljaard M, Li F (2022). Power analysis for cluster randomized trials with continuous co-primary endpoints. Biometrics.
    • (*Winner of 2022 ENAR Distinguished Student Paper Award*)
  16. Gettel CJ, Yiadom MYAB, Bernstein SL, Grudzen C, Nath B, Li F, Hwang U, Hess EP, Melnick ER (2022). Pragmatic clinical trial design in emergency medicine: Study considerations and design types. Academic Emergency Medicine.
  17. Chen X, Harhay MO, Li F (2022). Clustered restricted mean survival time regression. Biometrical Journal.
  18. Wang Y, Li F, Blaha O, Meng C, Esserman DA (2022). Design and analysis of partially randomized preference trials with propensity score stratification. Statistical Methods in Medical Research.
  19. Nicholls SG, Carroll K, Nix HP, Li F, Hey SP, Mitchell SL, Weijer C, Taljaard M (2022). Ethical considerations within pragmatic randomized controlled trials in dementia: Results from a literature survey. Alzheimer’s & Dementia: Translational Research & Clinical Interventions.
  20. Ghazi L, Li F, Chen X, Simonov M, Yamamoto Y, Biswas A, Hanna J, Shah T, Peixoto A, Wilson FP (2022). Blood pressure response to commonly administered antihypertensives for severe inpatient hypertension. PLoS ONE.
  21. Chen X, Li F (2022). Finite-sample adjustments in variance estimators for clustered competing risks regression. Statistics in Medicine.
  22. Li F, Lu W, Wang Y, Pan Z, Greene EJ, Meng G, Meng C, Blaha O, Zhao Y, Peduzzi PN, Esserman DA (2022). A comparison of analytical strategies for cluster randomized trials with survival outcomes in the presence of competing risks. Statistical Methods in Medical Research.
  23. Zhou T, Tong G, Li F, Thomas LE, Li F (2022). PSweight: An R package for propensity score weighting analysis. The R Journal.
  24. Li F, Buchanan AB, Cole SR (2022). Generalizing trial evidence to target populations in non-nested designs: Applications to AIDS clinical trials. Journal of the Royal Statistical Society: Series C (Applied Statistics).
  25. Cheng C, Spiegelman D, Li F (2022). Is the product method more efficient than the difference method for mediation analysis? American Journal of Epidemiology.
  26. Wang X, Turner EL, Li F, Wang R, Moyer J, Cook AJ, Murray DM, Heagerty PJ (2022). Two weights make a wrong: Cluster randomized trials with variable cluster sizes and heterogeneous treatment effects. Contemporary Clinical Trials.
  27. Zhou Y, Turner EL, Simmons R, Li F (2022). Constrained randomization and statistical inference for multi-arm parallel cluster randomized controlled trials. Statistics in Medicine.
  28. Tian Z, Esserman DA, Tong G, Blaha O, Dziura J, Peduzzi PN, Li F (2022). Sample size estimation in hierarchical 2 × 2 factorial trials accounting for unequal cluster sizes. Statistics in Medicine.
  29. Ghazi L, Li F, Chen X, Simonov M, Yamamoto Y, Biswas A, Hanna J, Shah T, Peixoto A, Wilson FP (2022). Severe inpatient hypertension prevalence and blood pressure response to antihypertensive treatment. Journal of Clinical Hypertension.

2021:

  1. Zeng S, Li F, Hu L, Li F (2021). Propensity score weighting analysis of survival outcomes using pseudo-observations. Statistica Sinica.
  2. Li F, Hong H, Stuart EA (2021). A note on semiparametric efficient generalization of causal effects from randomized trials to target populations. Communications in Statistics – Theory and Methods.
  3. Cheng C, Li F, Thomas LE, Li F (2021). Addressing extreme propensity scores in estimating counterfactual survival functions via the overlap weights. American Journal of Epidemiology.
  4. Luo J, Tang X, Li F, Wen H, Wang L, Ge S, Tang C, Xu N, Lu L (2021). Cigarette smoking and risk of different pathologic types of stroke: A systematic review and dose-response meta-analysis. Frontiers in Neurology.
  5. Tong G, Esserman DA, Li F (2021). Accounting for unequal cluster sizes in designing cluster randomized trials to detect treatment effect heterogeneity. Statistics in Medicine.
  6. Chen J, Xin Z, Li F, Spiegelman D (2021). swdpwr: A SAS macro and an R package for power calculation in stepped wedge cluster randomized trials. Computer Methods and Programs in Biomedicine.
  7. Chen X, Chang J, Spielgelman D, Li F (2021). A Bayesian approach for estimating the partial population impact fraction with exposure measurement error under a main study/internal validation design. Statistical Methods in Medical Research.
  8. Davis-Plourde K, Taljaard M, Li F* (2021). Sample size considerations for stepped wedge designs with subclusters. Biometrics.
    • (*Senior-author Paper Recognized by the 2022 Early Career Investigator Research Award at Yale School of Public Health*)
  9. Li F, Wang R (2021). Stepped wedge cluster randomized trials: A methodological overview. World Neurosurgery.
  10. Li F, Tian Z, Bobb JF, Papadogeorgou G, Li F (2021). Clarifying selection bias in cluster randomized trials. Clinical Trials.
  11. Cheng C, Spiegelman D, Li F (2021). Estimating natural indirect effect and mediation proportion via the product method. BMC Medical Research Methodology.
  12. Wang X, Turner EL, Preisser JS, Li F (2021). Power considerations for generalized estimating equations analyses of four-level cluster randomized trials. Biometrical Journal.
  13. Taljaard M, Li F, Qin B, Cui C, Zhang L, Nicholls SG, Carroll K, Mitchell SL (2021). Methodological challenges in pragmatic trials in Alzheimer’s disease and related dementias: Opportunities for improvement. Clinical Trials.
  14. Tong G, Seal K, Becker W, Li F, Dziura J, Peduzzi PN, Esserman DA (2021). Impact of complex, partially nested clustering in a three-arm individually randomized group treatment trial: A case study with the wHOPE trial. Clinical Trials.
  15. Tian Z, Preisser JS, Esserman DA, Turner EL, Rathouz PJ, Li F (2021). Impact of unequal cluster sizes for GEE analyses of stepped wedge cluster randomized trials with binary outcomes. Biometrical Journal.
  16. Yang S*, Li F, Thomas LE, Li F (2021). Covariate adjustment in subgroup analyses of randomized clinical trials: A propensity score approach. Clinical Trials. 18(5), 570-581.
    • (*Finalist of 2021 Society of Clinical Trials Thomas C. Chalmers Student Scholarship*)
  17. Hu L, Ji J, Li F (2021). Estimating heterogeneous survival treatment effect in observational data using machine learning. Statistics in Medicine. 40(21), 4691-4713.
  18. Wang Y, Jiang Y, Wei D, Singh P, Yu Y, Lee T, Zhang L, Mandl HK, Piotrowski-Daspit AS, Chen X, Li F, Li X, Cheng Y, Josowitz A, Yang F, Zhao Y, Wang F, Zhao Z, Huttner A, Bindra RS, Xiao H, Saltzman WM (2021). Nanoparticle-mediated convection-enhanced delivery of a DNA intercalator to gliomas circumvents temozolomide resistance. Nature Biomedical Engineering.
  19. Nugent J, Aklilu A, Yamamoto Y, Simonov M, Li F, Biswas A, Ghazi L, Greenberg J, Mansour S, Moledina D, Wilson FP (2021). Assessment of acute kidney injury and longitudinal kidney function after hospital discharge among patients with and without COVID-19. JAMA Network Open. 4(3), e211095.
  20. Li F, Tong G (2021). Sample size and power considerations for cluster randomized trials with count outcomes subject to right truncation. Biometrical Journal. 63(5), 1052-1071.
  21. Li F, Tong G (2021). Sample size estimation for modified Poisson analysis of cluster randomized trials with a binary outcome. Statistical Methods in Medical Research. 30(5), 1288-1305.
  22. Li F, Yu H, Rathouz PJ, Turner EL, Preisser JS (2021). Marginal modeling of cluster-period means and intraclass correlations in stepped wedge designs with a binary outcome. Biostatistics.

2020:

  1. Zeng S, Li F, Wang R, Li F (2020). Propensity score weighting for covariate adjustment in randomized clinical trials. Statistics in Medicine.
  2. Wegienka G, Stewart EA, Nicholson WK, Zhang S, Li F, Thomas L, Spies JB, Venable S, Laughlin-Tommaso S, Diamond MP, Anchan RM, Maxwell GL, Marsh EE, Myers ER, Vines AI, Wise LA, Wallace K, Jacoby VL (2020). Black women are more likely than White women to schedule a uterine-sparing treatment for Leiomyomas. Journal of Women’s Health.
  3. Shung D, Tsay C, Laine L, Chang D, Li F, Thomas P, Partridge C, Simonov M, Hsiao A, Tay KJ, Taylor A (2020). Early identification of patients with acute gastrointestinal bleeding using natural language processing and decision rules. Journal of Gastroenterology and Hepatology.
  4. Wilson FP, Martin M, Yamamoto Y, Partridge C, Moreira E, Arora T, Biswas A, Feldman H, Garg AX, Greenberg JH, Hinchcliff M, Latham S, Li F, Lin H, Mansour S, Moledina D, Palevsky PM, Parikh CR, Simonov M, Testani J, Ugwuowo U (2020). Electronic health record alerts for acute kidney injury: A multi-center randomized clinical trial. BMJ.
  5. Yu H, Tong G, Li F (2020). A note on the estimation and inference with quadratic inference functions for correlated outcomes. Communications in Statistics – Simulation and Computation.
  6. Yang S, Li F, Starks MA, Hernandez AF, Mentz RJ, Choudhury KR (2020). Sample size requirements for detecting treatment effect heterogeneity in cluster randomized trials. Statistics in Medicine. 39(28), 4218-4237.
  7. Yu H, Li F, Turner EL (2020). An evaluation of quadratic inference functions for estimating intervention effects in cluster randomized trials. Contemporary Clinical Trials Communications. 19:100605.
  8. Li F, Hughes JP, Hemming K, Taljaard M, Melnick ER, Heagerty PJ (2020). Mixed-effects models for the design and analysis of stepped wedge cluster randomized trials: An overview. Statistical Methods in Medical Research.
  9. Lu L, Li F, Wen H, Ge S, Zeng J, Luo W, Wang L, Tang C, Xu N (2020). An evidence mapping and analysis of registered COVID-19 clinical trials in China. BMC Medicine. 18(167), 1-10.
  10. Li F, Allen AS (2020). Secondary analysis of case-control association studies: Insights on weighting-based inference motivate a new specification test. Statistics in Medicine. 39(22), 2869-2882.
  11. Allore H, Goldfeld K, Gutman R, Li F, Monin J, Taljaard M, Travison T (2020). Statistical considerations for embedded pragmatic clinical trials in people living with dementia. Journal of the American Geriatrics Society. 68(S2), S68-S73.
  12. Li F, Harhay MO (2020). Commentary: Right truncation in cluster randomized trials can attenuate the power of a marginal analysis. International Journal of Epidemiology. 49(3), 964-967.
  13. Li F (2020). Comment: Stabilizing the doubly-robust estimators of the average treatment effect under positivity violations. Statistical Science. 35(3), 503-510.
  14. Gallis JA, Li F, Turner EL (2020). xtgeebcv: A command for bias-corrected sandwich variance estimation for GEE analyses of cluster randomized trials. The Stata Journal. 20(2), 363-381.
  15. Li F (2020). Design and analysis considerations for cohort stepped wedge cluster randomized trials with a decay correlation structure. Statistics in Medicine. 39(4), 438-455.
  16. Majoros WH, Barrera A, Kim Y-S, Li F, Wang X, Cunningham SJ, Johnson GD, Guo C, Lowe WL, Scholtens DM, Hayes MG, Reddy TE, Allen AS (2020). Bayesian estimation of genetic regulatory effects in high-throughput reporter assays. Bioinformatics. 36(2), 331-338.
  17. Turner EL, Yao L, Li F, Prague M (2020). Properties and pitfalls of weighting as an alternative to multilevel multiple imputation in cluster randomized trials with missing binary outcomes under covariate-dependent missingness. Statistical Methods in Medical Research. 29(5), 1338-1353.
  18. Logan J, Bauer C, Ke J, Xu H, Li F (2020). Models for small area estimation for Census Tracts. Geographical Analysis. 52(3), 325-350.

2019:

  1. Li F*, Li F (2019). Propensity score weighting for causal inference with multiple treatments. The Annals of Applied Statistics. 13(4), 2389-2415.
    • (*Winner of 2019 JSM Student Paper Award, ASA Biometrics Section*)
  2. Li F, Li K, Li C, Luo S (2019). Predicting the risk of Huntington’s disease with multiple longitudinal biomarkers. Journal of Huntington’s Disease. 8(3), 323-332.
  3. Yu H, Li F, Gallis JA, Turner EL (2019). cvcrand: A package for covariate-constrained randomization and the clustered permutation test for cluster randomization trials. The R Journal. 11(2), 191-204.
  4. Li F, Li F (2019). Double-robust estimation in difference-in-differences with an application to traffic safety evaluation. Observational Studies. 5, 1-20.
  5. Li F, Forbes AB, Turner EL, Preisser JS (2019). Power and sample size requirements for GEE analyses of cluster randomized crossover trials. Statistics in Medicine. 38(4), 636-649.
  6. Li F, Thomas LE, Li F (2019). Addressing extreme propensity scores via the overlap weights. American Journal of Epidemiology. 188(1), 250-257.

2018:

  1. Li F*, Turner EL, Preisser JS (2018). Sample size determination for GEE analyses of stepped wedge cluster randomized trials. Biometrics. 74(4), 1450-1458.
    • (*Winner of 2018 ENAR Distinguished Student Paper Award*)
  2. Logan J, Foster A, Ke J, Li F (2018). The uptick in income segregation: Real trend or random sampling variation? American Journal of Sociology. 124(1), 185-222.
  3. Gallis JA, Li F, Yu H, Turner EL (2018). cvcrand and cptest: Commands for efficient design and analysis of cluster randomized trials using constrained randomization and permutation tests. The Stata Journal. 18(2), 357-378.
  4. Li F, Turner EL, Preisser JS (2018). Optimal allocation of clusters in cohort stepped wedge designs. Statistics and Probability Letters. 137, 257-263.

2017:

  1. Zinszer B, Rolotti S, Li F, Li P (2017). Bayesian word learning in multiple language environments. Cognitive Science. 42(S2), 439-462.
  2. Assel MJ , Li F , Wang Y , Allen AS, Baggerly KA, Vickers AJ (2017). Genetic polymorphisms of CFH and ARMS2 do not predict response to antioxidants and zinc in patients with Age-Related Macular Degeneration: Independent statistical evaluations of data from the Age-Related Eye Disease Study. Ophthalmology. 125(3), 391-397.
  3. Li F, Turner EL, Heagerty PJ, Murray DM, Vollmer W, DeLong ER (2017). An evaluation of constrained randomization for the design and analysis of group-randomized trials with binary outcomes. Statistics in Medicine. 36(24), 3791-3806.
  4. Brennan JM, Thomas L, Cohen DJ, Shahian S, Wang A, Mack MJ, Holmes DR, Edwards FH, Frankel NZ, Baron SJ, Carroll J, Thourani V, Tuzcu EM, Arnold SV, Cohn R, Maser T, Schawe B, Strong S, Stickfort A, Patrick-Lake E, Graham FL, Dai D, Li F, Matsouaka RA, OBrien S, Li F, Pencina MJ, Peterson ED (2017). Transcatheter versus surgical aortic valve replacement: propensity-matched comparison. Journal of the American College of Cardiology. 70(4), 439-450.
  5. Turner EL, Prague M, Gallis J, Li F, Murray DM (2017). Review of recent methodological developments in group-randomized trials: Part 2–Analysis. American Journal of Public Health. 107(7), 1078-1086.
  6. Turner EL, Li F, Gallis J, Prague M, Murray DM (2017). Review of recent methodological developments in group-randomized trials: Part 1–Design. American Journal of Public Health. 107(6), 907-915.

2016 and prior:

  1. Benjamin Neelon SE, Mayhew M, O’Neill JR, Neelon B, Li F, Pate RR (2016). Comparative evaluation of a South Carolina policy to improve nutrition in child care. Journal of the Academy of Nutrition and Dietetics. 116(6), 949-956.
  2. Li F, Lokhnygina Y, Murray DM, Heagerty PJ, DeLong ER (2016). An evaluation of constrained randomization for the design and analysis of group-randomized trials. Statistics in Medicine. 35(10), 1565-1579.
  3. Neelon B, Li F*, Burgette LF, Benjamin Neelon SE (2015). A spatiotemporal quantile regression model for emergency department expenditures. Statistics in Medicine. 34(17), 2559-2575.
    • (*Winner of 2015 ICHPS Student Travel Award*)